These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20196921)

  • 1. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
    Seillier A; Giuffrida A
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):298-309. PubMed ID: 26706691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
    Vigano D; Guidali C; Petrosino S; Realini N; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):599-614. PubMed ID: 18789179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
    Ballmaier M; Bortolato M; Rizzetti C; Zoli M; Gessa G; Heinz A; Spano P
    Neuropsychopharmacology; 2007 Oct; 32(10):2098-107. PubMed ID: 17299506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A; Martinez AA; Giuffrida A
    Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia.
    Seillier A
    Exp Brain Res; 2024 May; 242(5):1149-1160. PubMed ID: 38489023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
    Seillier A; Giuffrida A
    Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
    Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
    Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.
    Zamberletti E; Piscitelli F; Cadeddu F; Rubino T; Fratta W; Fadda P; Di Marzo V; Parolaro D
    Br J Pharmacol; 2012 Dec; 167(8):1652-64. PubMed ID: 22762735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
    McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
    Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
    Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
    Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
    Mannucci C; Navarra M; Pieratti A; Russo GA; Caputi AP; Calapai G
    Nicotine Tob Res; 2011 Apr; 13(4):239-47. PubMed ID: 21324836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.
    Kjaerby C; Hovelsø N; Dalby NO; Sotty F
    J Neurophysiol; 2017 Aug; 118(2):1002-1011. PubMed ID: 28539393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.
    Haller J; Szirmai M; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2005 Sep; 16(5-6):415-22. PubMed ID: 16148446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
    Pedersen CS; Sørensen DB; Parachikova AI; Plath N
    Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.